The San Francisco biotech firm has pivoted to clinical execution after a four-year mammalian screening program.
Live Poll
Do you trust private biotech companies to successfully develop credible treatments to extend human lifespan?
September 28, 2026
UCSF Named First Qualified Center for WASKYRA TherapyThe FDA-approved gene therapy for Wiskott-Aldrich Syndrome is now commercially available in the United States.
September 18, 2026
Electra Therapeutics Raised $350 Million in IPOThe San Francisco-based biotech firm launched its public offering to secure capital for ongoing research and operations.
